263 Results for:

April 7, 2021

Diplomacy and International Institutions
Lessons Learned With Thomas Donilon

Thomas Donilon discusses his distinguished career in business and government, including his role as national security advisor under President Barack Obama, working with three U.S. presidents, serving…

Play National Security Advisor Tom Donilon speaks during a news conference on June 8, 2013 in Rancho Mirage, California.

June 16, 2021

New Zealand
Russell C. Leffingwell Lecture with Prime Minister Jacinda Ardern of New Zealand

Prime Minister Jacinda Ardern discusses the future of New Zealand's foreign policy and lessons learned from the country's response to COVID-19 and reopening.  This meeting kicks off the 2021 Virtu…

Play Screen grab of Arden zoom call with Richard Haass and Jacinda Ardern on screen.

June 9, 2021

Religion
Religion and Foreign Policy Webinar: 2021 Report on International Religious Freedom

Dwight Bashir, director of outreach and policy, and Elizabeth K. Cassidy, director of research and policy, both of the U.S. Commission on International Religious Freedom (USCIRF), present findings an…

Play 2021 Report on International Religious Freedom

September 15, 2020

CFR Master Class Series With Thomas Bollyky

For the first time in recorded history, bacteria, viruses, and other infectious agents do not cause the majority of deaths or disabilities in any region of the world. However, humankind's progress ag…

Play A scientist holds cells that produce antibodies against the coronavirus disease (COVID-19), in a university lab in Athens, Greece,

March 25, 2021

Immigration and Migration
Migration at the U.S.-Mexico Border

Paul Angelo, fellow for Latin America studies at the Council on Foreign Relations, discusses the migrant situation at the U.S.-Mexico border.   This webinar is part of the Religion and Fore…

Play Migration at the U.S.-Mexico Border

March 8, 2021

Pharmaceuticals and Vaccines
Vaccine Inequality and the Global Economic Recovery

Supply shortages and lackluster distribution rollouts of COVID-19 vaccines have plagued both developed and developing nations, complicating efforts to inoculate populations and reopen economies. As v…

Play Kenya to kick off coronavirus vaccination campaign with COVAX shots in Nairobi

February 18, 2021

Diplomacy and International Institutions
The Future of U.S. Diplomacy

Panelists discuss how diplomacy can be used to advance U.S. interests, and the function and responsibilities of ambassadors and embassies abroad. 

Play Mexican US resident Roberto Márquez, places a United States national flag on the border wall next to Rio Grande river to demonstrate against the immigration policies of Donald Trump in the border between El Paso, US, and Ciudad Juarez, Mexico, on June 6, 2019.

February 16, 2021

Transition 2021
Transition 2021 Series: Domestic Terrorism Post-Insurrection

Panelists discuss the rise of domestic terrorism in the United States, and the threat of white supremacist organizations, QAnon, disinformation and fake news, and conspiracy groups following the Janu…

Play Trump supporters gathered in the nation's capital today to protest the ratification of President-elect Joe Biden's Electoral College victory over President Trump in the 2020 election.

January 27, 2021

United States
Academic Webinar: American Isolationism vs. Internationalism

Charles A. Kupchan, senior fellow at CFR and professor of international affairs at Georgetown University’s School of Foreign Service and Department of Government, and Leslie Vinjamuri, director of th…

Play Person walking through field of American flags.

December 16, 2020

Public Health Threats and Pandemics
What's Next for the World Health Organization?

Panelists discuss the state of the World Health Organization, including the influence exerted by the United States and China, the organization's ability to coordinate a global vaccine, and its role i…

Play A medical syringe and a vial in front of the World Health Organization (WHO) logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as media reported on 18 November 2020.